Past Event
Past Event in Cardio-Metabolic
Discover past recorded events in the therapeutic area of cardio-metabolic
...
Did you mean: patients the?
NOVARTIS GENERAL PRIVACY NOTICE FOR HEALTHCARE PROFESSIONAL
At Novartis, we strive to be transparent in all our interactions. From time to time, Novartis Corporation (Malaysia) Sdn Bhd (referred as " Novartis " or " we " or " us ") solicits Personal Data from Healthcare Professional (“ HCP ”) with whom we intend...Dose adjustment
Non Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Non Hematologic ReactionsWell-characterized and manageable...
About Diovan®
Diovan ® (valsartan) is an orally active, potent and specific angiotensin receptor blocker (ARB). It acts selectively on the AT 1 receptor subtype, which is responsible for the known actions of angiotensin II (...
Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Hematologic ReactionsHematologic reactions are expected and manageable 1 ...
When to use JAKAVI (ruxolitinib)
When to use JAKAVI (ruxolitinib)Use JAKAVI as soon as patients are eligible to bring the most benefit to their lives 1-4 ...
About Exforge®
Exforge ® is indicated for treatment of essential hypertension, in patients whose blood pressure is not adequately controlled by monotherapy. It is also indicated for the...
×
Ask Speakers
×